A revolutionary drug , retatrutide, is sparking considerable buzz within the Oz weight loss community. Developed by Eli Lilly , this dual GIP and GLP-1 receiver appears to deliver more impressive benefits than present therapies. Early clinical research have shown noteworthy decreases in overall m